Baricitinib, a drug used to treat rheumatoid arthritis, was found to reduce deaths in hospitalized patients struggling with the SARS-CoV-2 coronavirus infection.
Individuals in whose bodies the antibody response did not evolve or develop fully, most often did not survive the SARS-CoV-2 infection, found the study